Literature DB >> 7539726

Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE).

H Liu1, K Ozaki, Y Matsuzaki, M Abe, M Kosaka, S Saito.   

Abstract

The inhibiting activity of serum on haematopoiesis has been described in patients with SLE. To explore further the features of serum inhibitor, we first examined the suppression of granulocytic and erythroid colony formation in vitro by serum from patients with SLE using methylcellulose culture. The potent inhibiting activity was demonstrated in six of 20 patients. All of these six patients were associated with leukocytopenia and/or anaemia. Five of 10 sera from patients with active SLE suppressed the colony formation of both burst-forming units of erythrocyte (BFU-E) and colony-forming units of granulocyte/macrophage (CFU-GM), and one serum suppressed BFU-E only. IgG fraction isolated from sera with inhibiting activity suppressed colony formation without complement involvement. The elimination of monocytes and lymphocytes from target mononuclear cells did not affect the suppression by the IgG fractions. The suppressive effect was completely eliminated after incubation of the IgG fractions with progenitor-enriched mononuclear cells. Flow cytometric analysis showed these IgG bound to CD34+ haematopoietic progenitor cells, but not to CD33+ cells. These data suggest that (i) the inhibitor of colony formation in serum was observed in IgG fraction; (ii) its suppressive effect on colony formation was mediated by neither monocytes and lymphocytes nor complements; and (iii) IgG fraction could bind to primitive haematopoietic progenitor cells and suppress the growth of these cells. Thus, IgG autoantibodies to primitive haematopoietic progenitor cells are demonstrated to be present in the sera of a significant proportion of active SLE patients with anaemia and leukocytopenia and to suppress the progenitor cell growth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539726      PMCID: PMC1534483          DOI: 10.1111/j.1365-2249.1995.tb03726.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia.

Authors:  F A Bailey; M Lilly; L F Bertoli; G V Ball
Journal:  Arthritis Rheum       Date:  1989-07

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis.

Authors:  J J Fitchen; M J Cline; A Saxon; D W Golde
Journal:  Am J Med       Date:  1979-03       Impact factor: 4.965

4.  Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A.

Authors:  N N Iscove; F Sieber; K H Winterhalter
Journal:  J Cell Physiol       Date:  1974-04       Impact factor: 6.384

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

Review 6.  NIH conference. Systemic lupus erythematosus.

Authors:  A D Steinberg; M F Gourley; D M Klinman; G C Tsokos; D E Scott; A M Krieg
Journal:  Ann Intern Med       Date:  1991-10-01       Impact factor: 25.391

7.  Serum inhibitors of myelopoiesis.

Authors:  J H Fitchen; M J Cline
Journal:  Br J Haematol       Date:  1980-01       Impact factor: 6.998

8.  Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia.

Authors:  B J Brooks; H E Broxmeyer; C F Bryan; S H Leech
Journal:  Arch Intern Med       Date:  1984-07

9.  Antibodies to granulocyte precursors in selective myeloid hypoplasia and other suspected autoimmune neutropenias: use of HL-60 cells as targets.

Authors:  M S Currie; J B Weinberg; P K Rustagi; G L Logue
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

10.  Granulopoiesis in systemic lupus erythematosus.

Authors:  K Yamasaki; Y Niho; T Yanase
Journal:  Arthritis Rheum       Date:  1983-04
View more
  11 in total

Review 1.  Neutrophils in the pathogenesis and manifestations of SLE.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

2.  Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.

Authors:  Peter E Westerweel; Remco K M A C Luijten; Imo E Hoefer; Hein A Koomans; Ronald H W M Derksen; Marianne C Verhaar
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

Review 3.  Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.

Authors:  S Giannouli; M Voulgarelis; P D Ziakas; A G Tzioufas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

Review 4.  Endothelial progenitor cell dysfunction in rheumatic disease.

Authors:  Peter E Westerweel; Marianne C Verhaar
Journal:  Nat Rev Rheumatol       Date:  2009-06       Impact factor: 20.543

5.  Systemic Lupus Erythematosus is a Risk Factor for Complications in Total Joint Arthroplasty.

Authors:  J Joseph Gholson; Brandon G Wilkinson; Timothy S Brown; Yubo Gao; S Blake Dowdle; John J Callaghan
Journal:  Iowa Orthop J       Date:  2018

Review 6.  Primary and secondary autoimmune neutropenia.

Authors:  Franco Capsoni; Piercarlo Sarzi-Puttini; Alberto Zanella
Journal:  Arthritis Res Ther       Date:  2005-08-31       Impact factor: 5.156

7.  Pure Red Cell Aplasia with Adult Onset Still's Disease.

Authors:  Nicholas Robillard; Paul Van Nguyen; Robert Wistaff; Mikhael Laskine
Journal:  Case Rep Med       Date:  2013-09-02

8.  Lower In-Hospital Mortality with Plasma Exchange than Plasmapheresis in a Subgroup Analysis of 374 Lupus Patients.

Authors:  Yu-Jih Su; Wen-Chan Chiu; Chung-Yuan Hsu; Jin-Bor Chen; Hwee-Yeong Ng
Journal:  Biomed Res Int       Date:  2018-05-02       Impact factor: 3.411

9.  Increased level of B cell differentiation factor in systemic lupus erythematosus patients.

Authors:  Hala Zaki Raslan; Hiba Sibaii; Salwa Refat El-Zayat; Hagar Hassan; Mahitab El-Kassaby
Journal:  J Genet Eng Biotechnol       Date:  2018-05-30

10.  Altered frequency of peripheral B-cell subsets and their correlation with disease activity in patients with systemic lupus erythematosus: A comprehensive analysis.

Authors:  Yanxia Peng; Fengbiao Guo; Shuzhen Liao; Huanjin Liao; Haiyan Xiao; Lawei Yang; Hua-Feng Liu; Qingjun Pan
Journal:  J Cell Mol Med       Date:  2020-09-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.